Table 3.

Recommended HCV Treatment Regimen for Patients with Decompensated Cirrhosis.

Genotype	Recommended regimen
1 & 4	• SOF + LDV + RBV (initial dose of 600 mg, increased as tolerated) × 12 weeks • SOF + DCV + RBV (initial dose of 600 mg, increased as tolerated) × 12 weeks Alternative regimen for RBV-intolerant patients • SOF + DCV × 24 weeks • SOF + LDV × 12 weeks
2	• SOF + DCV + RBV (initial dose of 600 mg, increased as tolerated) × 12 weeks
3	• SOF + DCV + RBV (initial dose of 600 mg, increased as tolerated) × 24 weeks Alternative regimen • SOF + RBV (initial dose of 600 mg, increased as tolerated) for up to 48 weeks

DCV, daclatasvir (60 mg); LDV, ledipasvir (90 mg); RBV, Ribavirin; SOF, sofosbuvir